Mobile Elements in the Human Genome: Implications for Disease


Transposable elements (TEs) are mobile DNA (deoxyribonucleic acid) sequences that represent a great portion of the human genome. TEs are divided into retrotransposons, the more abundant, and DNA transposons, which differ by their structure and transposition mechanisms. The major LINE‐1 and Alu elements represent about one‐third of the human genome and are responsible for several chromosomal rearrangements, gene deletion, insertional mutagenesis as well as RNA (ribonucleic acid) splicing alteration and epigenetic regulation. DNA transposons and human endogenous retroviruses are also a source of genetic alterations. Consequently, TE insertion and mobility lead to human diseases, among which are cancer, hematologic disease, metabolic disease, neurodegenerescence and neurologic and psychiatric diseases. The examples of TE‐related diseases presented herein aim to highlight the interest of increasing our knowledge of TEs through extensive genomic approaches, which may lead to new potential diagnostic markers of diseases.

Key Concepts

  • Transposable elements are numerous in the human genome, and the most abundant Alu and LINE‐1 retroelements represent about one‐third of the human genome.
  • Transposable elements are a source of genomic rearrangements that may lead to several human diseases.
  • Gene expression may be affected by transposable elements through the modification of regulatory elements and RNA splicing events.
  • Transposable elements impact and are impacted by epigenetic regulation.
  • Examples of human diseases related to transposable elements include (but are not limited to) cancer, hematologic, metabolic and neurologic diseases.

Keywords: transposable elements; transposon; retrotransposon; human disease; chromosome rearrangement; gene recombination; cancer; neurologic disease; metabolic disease; genetic disease

Figure 1. Proportion of TEs (transposable elements) in the human genome (Chénais, ). The percentage of each class or subclass of TEs is indicated with respect to the whole genome according to data from Lander et al. . Adapted from Chénais B (2015) Transposable elements in cancer and other human diseases. Current Cancer Drug Targets 15(3): 227–242.
Figure 2. Simplified view of the main consequences of TE insertion on mRNA splicing. (a) Exonisation; (b) exon skipping; (c) intron retention. Red box corresponds to the TE and coloured boxes correspond to exons; introns are represented by black lines; dashed lines indicate the splicing events (Chénais, ). Adapted from Chénais B (2015) Transposable elements in cancer and other human diseases. Current Cancer Drug Targets 15(3): 227–243.


Baust C, Seifarth W, Germaier H, Hehlmann R and Leib‐Mosch C (2000) HERV‐K‐T47D‐related long terminal repeats mediate polyadenylation of cellular transcripts. Genomics 66 (1): 98–103.

Bundo M, Toyoshima M, Okada Y, et al. (2014) Increased l1 retrotransposition in the neuronal genome in schizophrenia. Neuron 81 (2): 306–313.

Chénais B (2015) Transposable elements in cancer and other human diseases. Current Cancer Drug Targets 15 (3): 227–242.

Clayton EA, Wang L, Rishishwar L, et al. (2016) Patterns of transposable element expression and insertion in cancer. Frontiers in Molecular Biosciences 3: 76.

Ecsedi SI, Hernandez‐Vargas H, Lima SC, et al. (2013) Transposable hypomethylation is associated with metastatic capacity of primary melanomas. International Journal of Clinical and Experimental Pathology 6 (12): 2943–2948.

Ferlini A, Galie N, Merlini L, et al. (1998) A novel Alu‐like element rearranged in the dystrophin gene causes a splicing mutation in a family with X‐linked dilated cardiomyopathy. American Journal of Human Genetics 63 (2): 436–446.

Ferreira PG, Jares P, Rico D, et al. (2014) Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Research 24 (2): 212–226.

Franke G, Bausch B, Hoffmann MM, et al. (2009) Alu‐Alu recombination underlies the vast majority of large VHL germline deletions: molecular characterization and genotype‐phenotype correlations in VHL patients. Human Mutation 30 (5): 776–786.

Ganguly A, Dunbar T, Chen P, Godmilow L and Ganguly T (2003) Exon skipping caused by an intronic insertion of a young Alu YB9 element leads to severe hemophilia A. Human Genetics 113 (4): 348–352.

Grégoire L, Haudry A and Lerat E (2016) The transposable element environment of human genes is associated with histone and expression changes in cancer. BMC Genomics 17: 588.

Guffanti G, Gaudi S, Fallon JH, et al. (2014) Transposable elements and psychiatric disorders. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 165B (3): 201–216.

Harteveld KL, Losekoot M, Fodde R, Giordano PC and Bernini LF (1997) The involvement of Alu repeats in recombination events at the alpha‐globin gene cluster: characterization of two alphazero‐thalassaemia deletion breakpoints. Human Genetics 99 (4): 528–534.

Henthorn PS, Mager DL, Huisman TH and Smithies O (1986) A gene deletion ending within a complex array of repeated sequences 3′ to the human beta‐globin gene cluster. Proceedings of the National Academy of Sciences of the United States of America 83 (14): 5194–5198.

Hobbs HH, Brown MS and Goldstein JL (1992) Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Human Mutation 1 (6): 445–466.

Hsieh SY, Chen WY, Yeh TS, Sheen IS and Huang SF (2005) High‐frequency Alu‐mediated genomic recombination/deletion within the caspase‐activated DNase gene in human hepatoma. Oncogene 24 (43): 6584–6589.

Huang LS, Ripps ME, Korman SH, Deckelbaum RJ and Breslow JL (1989) Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu‐Alu recombination. The Journal of Biological Chemistry 264 (19): 11394–11400.

Jeffs AR, Benjes SM, Smith TL, Sowerby SJ and Morris CM (1998) The BCR gene recombines preferentially with Alu elements in complex BCR‐ABL translocations of chronic myeloid leukaemia. Human Molecular Genetics 7 (5): 767–776.

Jelassi A, Slimani A, Rabes JP, et al. (2012) Genomic characterization of two deletions in the LDLR gene in tunisian patients with familial hypercholesterolemia. Clinica Chimica Acta 414: 146–151.

Kidd JM, Graves T, Newman TL, et al. (2010) A human genome structural variation sequencing resource reveals insights into mutational mechanisms. Cell 143 (5): 837–847.

Knebelmann B, Forestier L, Drouot L, et al. (1995) Splice‐mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Human Molecular Genetics 4 (4): 675–679.

de Koning AP, Gu W, Castoe TA, Batzer MA and Pollock DD (2011) Repetitive elements may comprise over two‐thirds of the human genome. PLoS Genetics 7 (12): e1002384.

Kornreich R, Bishop DF and Desnick RJ (1990) Alpha‐galactosidase A gene rearrangements causing Fabry disease. Identification of short direct repeats at breakpoints in an Alu‐rich gene. The Journal of Biological Chemistry 265 (16): 9319–9326.

Lander ES, Linton LM, Birren B, et al. (2001) Initial sequencing and analysis of the human genome. Nature 409 (6822): 860–921.

Landry JR, Rouhi A, Medstrand P and Mager DL (2002) The Opitz syndrome gene MID1 is transcribed from a human endogenous retroviral promoter. Molecular Biology and Evolution 19 (11): 1934–1942.

Lanikova L, Kucerova J, Indrak K, et al. (2013) Beta‐thalassemia due to intronic LINE‐1 insertion in the beta‐globin gene (HBB): molecular mechanisms underlying reduced transcript levels of the beta‐globin(L1) allele. Human Mutation 34 (10): 1361–1365.

Lee E, Iskow R, Yang L, et al. (2012) Landscape of somatic retrotransposition in human cancers. Science 337 (6097): 967–971.

Li W, Jin Y, Prazak L, Hammell M and Dubnau J (2012) Transposable elements in TDP‐43‐mediated neurodegenerative disorders. PLoS One 7 (9): e44099.

Mager DL, Hunter DG, Schertzer M and Freeman JD (1999) Endogenous retroviruses provide the primary polyadenylation signal for two new human genes (HHLA2 and HHLA3). Genomics 59 (3): 255–263.

Martinez‐Garay I, Ballesta MJ, Oltra S, et al. (2003) Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin‐Lowry syndrome. Clinical Genetics 64 (6): 491–496.

Meischl C, Boer M, Ahlin A and Roos D (2000) A new exon created by intronic insertion of a rearranged LINE‐1 element as the cause of chronic granulomatous disease. European Journal of Human Genetics 8 (9): 697–703.

Mine M, Chen JM, Brivet M, et al. (2007) A large genomic deletion in the PDHX gene caused by the retrotranspositional insertion of a full‐length LINE‐1 element. Human Mutation 28 (2): 137–142.

Mitchell GA, Labuda D, Fontaine G, et al. (1991) Splice‐mediated insertion of an Alu sequence inactivates ornithine delta‐aminotransferase: a role for Alu elements in human mutation. Proceedings of the National Academy of Sciences of the United States of America 88 (3): 815–819.

Morse B, Rotherg PG, South VJ, Spandorfer JM and Astrin SM (1988) Insertional mutagenesis of the MYC locus by a LINE‐1 sequence in a human breast carcinoma. Nature 333 (6168): 87–90.

Narita N, Nishio H, Kitoh Y, et al. (1993) Insertion of a 5′ truncated L1 element into the 3′ end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy. The Journal of Clinical Investigation 91 (5): 1862–1867.

Neote K, McInnes B, Mahuran DJ and Gravel RA (1990) Structure and distribution of an Alu‐type deletion mutation in Sandhoff disease. The Journal of Clinical Investigation 86 (5): 1524–1531.

O'Neil J, Tchinda J, Gutierrez A, et al. (2007) Alu elements mediate MYB gene tandem duplication in human T‐ALL. The Journal of Experimental Medicine 204 (13): 3059–3066.

Oldridge M, Zackai EH, McDonald‐McGinn DM, et al. (1999) De novo Alu‐element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. American Journal of Human Genetics 64 (2): 446–461.

Oliveira C, Senz J, Kaurah P, et al. (2009) Germline CDH1 deletions in hereditary diffuse gastric cancer families. Human Molecular Genetics 18 (9): 1545–1555.

Onno M, Nakamura T, Hillova J and Hill M (1992) Rearrangement of the human tre oncogene by homologous recombination between Alu repeats of nucleotide sequences from two different chromosomes. Oncogene 7 (12): 2519–2523.

Phylipsen M, Vogelaar IP, Schaap RA, et al. (2010) A new alpha(0)‐thalassemia deletion found in a Dutch family (−−(aw)). Blood Cells, Molecules and Diseases 45 (2): 133–135.

Rodic N, Zampella JG, Cornish TC, Wheelan SJ and Burns KH (2013) Translocation junctions in TCF3‐PBX1 acute lymphoblastic leukemia/lymphoma cluster near transposable elements. Mobile DNA 4 (1): 22.

Ross JP, Rand KN and Molloy PL (2010) Hypomethylation of repeated DNA sequences in cancer. Epigenomics 2 (2): 245–269.

Saito K and Siomi MC (2010) Small RNA‐mediated quiescence of transposable elements in animals. Developmental Cell 19 (5): 687–697.

Shabbeer J, Yasuda M, Benson SD and Desnick RJ (2006) Fabry disease: identification of 50 novel alpha‐galactosidase a mutations causing the classic phenotype and three‐dimensional structural analysis of 29 missense mutations. Human Genomics 2 (5): 297–309.

Tang Z, Steranka JP, Ma S, et al. (2017) Human transposon insertion profiling: analysis, visualization and identification of somatic line‐1 insertions in ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America 114 (5): E733–E740.

Tubio JM, Li Y, Ju YS, et al. (2014) Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science 345 (6196): 1251343.

Vervoort R, Gitzelmann R, Lissens W and Liebaers I (1998) A mutation (IVS8 + 0.6kbdeltc) creating a new donor splice site activates a cryptic exon in an alu‐element in intron 8 of the human beta‐glucuronidase gene. Human Genetics 103 (6): 686–693.

Wallace MR, Andersen LB, Saulino AM, et al. (1991) A de novo Alu insertion results in neurofibromatosis type 1. Nature 353 (6347): 864–866.

Yu J, Xie J, Luo L and Li Z (2014) An Alu element‐mediated 28.5 kb alpha‐thalassemia deletion found in a chinese family. Hemoglobin 38 (6): 427–430.

Further Reading

Chénais B, Caruso A, Hiard S and Casse N (2012) The impact of transposable elements on eukaryotic genomes: from genome size increase to genetic adaptation to stressful environments. Gene 509 (1): 7–15.

Chénais B (2013) Transposable elements and human cancer: a causal relationship? Biochimica et Biophysica Acta 1835 (1): 28–35.

Cordaux R and Batzer MA (2009) The impact of retrotransposons on human genome evolution. Nature Reviews. Genetics 10 (10): 691–703.

Feschotte C and Pritham EJ (2007) DNA transposons and the evolution of eukaryotic genomes. Annual Review of Genetics 41: 331–368.

Kulis M, Queiros AC, Beekman R and Martin‐Subero JI (2013) Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer. Biochimica et Biophysica Acta 1829 (11): 1161–1174.

Levin HL and Moran JV (2011) Dynamic interactions between transposable elements and their hosts. Nature Reviews. Genetics 12 (9): 615–627.

Mazoyer S (2005) Genomic rearrangements in the BRCA1 and BRCA2 genes. Human Mutation 25 (5): 415–422.

Reilly MT, Faulkner GJ, Dubnau J, Ponomarev I and Gage FH (2013) The role of transposable elements in health and diseases of the central nervous system. Journal of Neuroscience 33 (45): 17577–17586.

Roy‐Engel AM, El‐Sawy M, Farooq L, et al. (2005) Human retroelements may introduce intragenic polyadenylation signals. Cytogenetic and Genome Research 110 (1–4): 365–371.

Sinzelle L, Izsvak Z and Ivics Z (2009) Molecular domestication of transposable elements: from detrimental parasites to useful host genes. Cellular and Molecular Life Sciences 66 (6): 1073–1093.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Chénais, Benoît(Dec 2017) Mobile Elements in the Human Genome: Implications for Disease. In: eLS. John Wiley & Sons Ltd, Chichester. [doi: 10.1002/9780470015902.a0024377]